disease-modifying antirheumatic drugs
OBJECTIVES: Methotrexate is currently one of the most widely prescribed       disease-modifying antirheumatic drugs (DMARDs) for the treatment of rheumatoid       arthritis (RA).
OBJECTIVES: Methotrexate is currently one of the most widely prescribed        @SUBJECT$  (DMARDs) for the  @PREDICAT$  of  @OBJECT$  (RA).